Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy in the elderly: pharmacologic considerations.

S M Lichtman1, G Villani

  • 1Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital-New York University School of Medicine, Manhasset 11030, USA. lichtman@nshs.edu

Cancer Control : Journal of the Moffitt Cancer Center
|November 23, 2000
PubMed
Summary

Chemotherapy can be beneficial for elderly cancer patients. Careful dose adjustments considering age-related physiological changes and organ function are essential for safe and effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taking the next step in PARP-inhibitor clinical trials in older women with ovarian cancer - Staging the aging.

Gynecologic oncology reports·2021
Same author

<i>In Vitro</i> Apoptotic Effects of Farnesyltransferase blockade in Acute Myeloid Leukemia Cells.

Translational medicine @ UniSa·2016
Same author

Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment.

Translational medicine @ UniSa·2016
Same author

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Leukemia & lymphoma·2016
Same author

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

[Branch block of exertion].

Folia cardiologica·2014

Area of Science:

  • Geriatric Oncology
  • Pharmacology
  • Cancer Therapeutics

Background:

  • Growing elderly population necessitates specialized cancer care.
  • Understanding chemotherapy

Purpose of the Study:

  • To evaluate the safety and efficacy of chemotherapy in elderly cancer patients.
  • To review recent data on chemotherapeutic agents for older adults.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of pharmacokinetic data for select chemotherapeutic agents.

Main Results:

  • Several agents, including gemcitabine, vinorelbine, taxanes, anthracyclines, platinum compounds, topoisomerase inhibitors, and oral fluoropyrimidines, show a favorable therapeutic index in the elderly.

Related Experiment Videos

  • These agents demonstrate potential benefit in older cancer patients.

    • Conclusions:

    • Safe chemotherapy administration in the elderly requires attention to age-related physiological changes.
    • Dose adjustments for renal and hepatic dysfunction are crucial for optimizing treatment outcomes in older patients.